Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer

NCT01642251 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

156

Enrollment

NIH

Sponsor class

Conditions

Extensive Stage Small Cell Lung Carcinoma
Large Cell Lung Carcinoma
Neuroendocrine Carcinoma
Small Cell Carcinoma
Stage IV Non-Small Cell Lung Cancer AJCC v7

Interventions

DRUG: Cisplatin
DRUG: Etoposide
DRUG: Veliparib
DRUG: Placebo

Sponsor

National Cancer Institute (NCI)